How long does it take for Sotoraxibu (AMG510) to take effect?

Sotoracib (AMG510) is a targeted therapy drug whose duration of action varies depending on individual differences and disease status. Typically, the onset of effects of sotoraxib can be seen weeks to months after treatment is initiated.

After using sotoraxib for the first time, the drug will quickly enter the body and begin to interact withKRAS G12C mutant protein, inhibiting its activity. However, because tumor cells have different growth rates and metabolic properties, the duration of action of sotoraxib varies among individuals. In some patients, sotoraxib may show significant therapeutic effects within weeks of starting treatment. These effects may include tumor shrinkage, improvement in symptoms, and improvements in related indicators such as tumor markers. However, in other patients, treatment effects may take longer to be observed.

In a clinical study of sotorasiib, 45 of 124 people (36%) had their non-small cell lung cancer tumors disappear or shrink by at least 30%. The median duration of response was 10 months. In another study, the 12-month progression-free survival rate was 24.8% in the sotoraxib arm compared with 10.1% in the chemotherapy drug docetaxel arm.

In addition, as a long-term treatment drug, sotoraxib usually requires continued use to maintain therapeutic effects. Doctors will develop a treatment plan based on the patient's specific situation and disease progression. The use of sotoracib should be guided by your doctor's instructions and recommendations. If patients experience any discomfort or side effects while using sotoraxib, they should report it to their doctor in time. The doctor will evaluate the patient's specific situation and adjust the treatment plan to provide the best possible results.